“miR-145-5p and miR-203a-5p overcome imatinib resistance in myelogenous leukemic cells through metabolic reprogramming”, IJBB, vol. 60, no. 3, pp. 167–176, Jun. 2023, doi: 10.56042/ijbb.v60i3.66526.